The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
Open accessAbstract
Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Even in the presence of donor template DNA, NHEJ is the more frequent repair mechanism observed from CRISPR/Cas9 editing (Maruyama et al., 2015).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Maruyama et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“or inhibiting the NHEJ pathway [113] have shown to be useful as means of increasing the efficiency of HDR after Cas9 cleavage.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [113]
In the citing paper
“Although inhibiting the NHEJ pathway with gene silencing or chemical inhibitors can partially increase the efficiency of HDR pathway, the gene repair efficacy still needs to be further improved for disease therapy [82, 85].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Double-strand break repair: 53BP1 comes into focus
Panier, S., & Boulton, S. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3719 · Cited by 1,168
Kamentsky, L. D., Jones, T. R., Fraser, A. N., Bray, M., Logan, D. J., Madden, K. L., Ljosa, V., Rueden, C., Eliceiri, K. W., & Carpenter, A. E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr095 · Cited by 1,002
Cited by
Sorted by citations
Items 501–600 of 1,000
Therapeutic genome engineering via CRISPR ‐Cas systems
Moreno, A. M., & Mali, P. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1380 · Cited by 25
A CRISPR /LbCas12a‐based method for highly efficient multiplex gene editing in Physcomitrella patens
Pu, X., Liu, L., Li, P., Huo, H., Dong, X., Xie, K., Yang, H., & Liu, L. (2019) · The Plant Journal · doi:10.1111/tpj.14478 · Cited by 25
Sato, M., Miyagasako, R., Takabayashi, S., Ohtsuka, M., Hatada, I., & Horii, T. (2020) · Cells · doi:10.3390/cells9030546 · Cited by 25
Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease
Baker, C. M., & Hayden, M. S. (2020) · F1000Research · doi:10.12688/f1000research.23185.1 · Cited by 26
Ophinni, Y., Miki, S., Hayashi, Y., & Kameoka, M. (2020) · Viruses · doi:10.3390/v12111223 · Cited by 25
A Cas9–transcription factor fusion protein enhances homology-directed repair efficiency
Li, G., Wang, H., Zhang, X., Wu, Z., & Yang, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100525 · Cited by 25
Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions
Zhu, X., Zhang, Y., Yang, X., Hao, C., & Duan, H. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.618171 · Cited by 25
Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing
Denes, C. E., Cole, A. J., Aksoy, Y. A., Li, G., Neely, G. G., & Hesselson, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168571 · Cited by 28
Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases
Schreurs, J., Sacchetto, C., Colpaert, R. M. W., Vitiello, L., Rampazzo, A., & Calore, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010985 · Cited by 25
Gene editing innovations and their applications in cardiomyopathy research
Kyriakopoulou, E., Monnikhof, T., & van Rooij, E. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050088 · Cited by 26
Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing
Kaulich, M., & Dowdy, S. F. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0545 · Cited by 25
Periwal, V. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw052 · Cited by 25
CRISPR editing in biological and biomedical investigation
Huang, J., Wang, Y., & Zhao, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26141 · Cited by 25
Liu, J., & Shui, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.014 · Cited by 24
Jacobsen, J. T., Mesin, L., Markoulaki, S., Schiepers, A., Cavazzoni, C. B., Bousbaine, D., Jaenisch, R., & Victora, G. D. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172064 · Cited by 24
Targeted gene knockin in zebrafish using the 28S rDNA-specific non-LTR-retrotransposon R2Ol
Kuroki-Kami, A., Nichuguti, N., Yatabe, H., Mizuno, S., Kawamura, S., & Fujiwara, H. (2019) · Mobile DNA · doi:10.1186/s13100-019-0167-2 · Cited by 23
Hu, M., Cherkaoui, I., Misra, S., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.576632 · Cited by 24
Maganti, H. B., Bailey, A. J.-M., Kirkham, A. M., Shorr, R., Pineault, N., & Allan, D. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0520 · Cited by 24
CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases
Rasoulinejad, S. A., & Maroufi, F. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00345-4 · Cited by 24
Yan, Z., Vorhies, K., Feng, Z., Park, S. Y., Choi, S. H., Zhang, Y., Winter, M. C., Sun, X., & Engelhardt, J. F. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.036 · Cited by 24
Perspectives of gene editing for cattle farming in tropical and subtropical regions
Camargo, L. S. A., Saraiva, N. Z., Oliveira, C. S., Carmickle, A. T., de Lemos, D. R., Siqueira, L. G. B., & Denicol, A. C. (2022) · Animal Reproduction · doi:10.1590/1984-3143-ar2022-0108 · Cited by 28
Accelerated genome engineering through multiplexing
Bao, Z., Cobb, R. E., & Zhao, H. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1319 · Cited by 24
Tamai, M., Inukai, T., Kojika, S., Abe, M., Kagami, K., Harama, D., Shinohara, T., Watanabe, A., Oshiro, H., Akahane, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27767-6 · Cited by 24
Genome editing in the mammalian brain using the CRISPR–Cas system
Nishiyama, J. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.07.003 · Cited by 25
Harnessing CRISPR/Cas9 technology in cardiovascular disease
Rezaei, H., Khadempar, S., Farahani, N., Hosseingholi, E. Z., Hayat, S. M. G., Sathyapalan, T., & Sahebkar, A. H. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.03.005 · Cited by 24
Single-cell quantification of the concentrations and dissociation constants of endogenous proteins
Komatsubara, A. T., Goto, Y., Kondo, Y., Matsuda, M., & Aoki, K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007685 · Cited by 24
CRISPR/Cas9: A new tool for the study and control of helminth parasites
Du, X., McManus, D. P., French, J. D., Jones, M. K., & You, H. (2020) · BioEssays · doi:10.1002/bies.202000185 · Cited by 24
TALENs-Assisted Multiplex Editing for Accelerated Genome Evolution To Improve Yeast Phenotypes
Zhang, G., Lin, Y., Qi, X., Li, L., Wang, Q., & Ma, Y. (2015) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00074 · Cited by 24
In vivo gene therapy potentials of CRISPR-Cas9
Xue, H.-Y., Zhang, X., Wang, Y., Lu, X., Dai, W.-J., & Xu, Y. C. (2016) · Gene Therapy · doi:10.1038/gt.2016.25 · Cited by 24
Overview of CRISPR–Cas9 BiologyPreprint
Ratner, H. K., Sampson, T. R., & Weiss, D. S. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top088849 · Cited by 28
In Vivo Genome Editing in Type I and II Methanotrophs Using a CRISPR/Cas9 System
Rumah, B. L., Stevens, B. H. C., Yeboah, J. E., Stead, C. E., Harding, E. L., Minton, N. P., & Zhang, Y. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00554 · Cited by 23
Progress and Prospects of Gene Editing in Pluripotent Stem Cells
Zhang, Z., Bao, X., & Lin, C. (2023) · Biomedicines · doi:10.3390/biomedicines11082168 · Cited by 23
Jubair, L., & McMillan, N. A. J. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.006 · Cited by 23
Uno, N., Hiramatsu, K., Uno, K., Komoto, S., Kazuki, Y., & Oshimura, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10418-7 · Cited by 24
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle, C. F., & MacLaren, R. E. (2017) · PubMed · Cited by 23
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering
van der Schoot, J. M. S., Fennemann, F. L., Valente, M., Dölen, Y., Hagemans, I. M., Becker, A. M. D., Gall, C. M. L., van Dalen, D., Çevirgel, A., van Bruggen, J. A. C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw1822 · Cited by 23
CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies
Ureña-Bailén, G., Lamsfus‐Calle, A., Daniel-Moreno, A., Raju, J., Schlegel, P., Seitz, C. M., Atar, D., Antony, J. S., Handgretinger, R., & Mezger, M. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz039 · Cited by 23
Chlamydomonas POLQ is necessary for CRISPR/Cas9-mediated gene targeting
Sizova, I. A., Kelterborn, S., Verbenko, V. N., Kateriya, S., & Hegemann, P. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab114 · Cited by 23
Tahir, T., Ali, Q., Rashid, M., & Malik, A. (2020) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2020i1.17 · Cited by 23
CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish
Gonzãlez, F. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24414 · Cited by 22
Applications of the CRISPR-Cas9 system in kidney research
Higashijima, Y., Hirano, S., Nangaku, M., & Nureki, O. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.037 · Cited by 22
Bennett, H. J., Aguilar-Martínez, E., & Adamson, A. D. (2020) · Methods · doi:10.1016/j.ymeth.2020.10.012 · Cited by 22
Leptin gene-targeted editing in ob/ob mouse adipose tissue based on the CRISPR/Cas9 system
Zhu, L., Yang, X., Li, J., Jia, X., Bai, X., Zhao, Y., Cheng, W., Shu, M., Zhu, Y., & Jin, S. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.01.008 · Cited by 22
From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods
Bazaz, M. R., & Dehghani, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120409 · Cited by 23
Generation of genetically modified mice using CRISPR/Cas9 and haploid embryonic stem cell systems.
Jin, L., & Li, J. (2016) · Europe PMC (PubMed Central) · doi:10.13918/j.issn.2095-8137.2016.4.205 · Cited by 22
Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease
Lau, C., & Suh, Y. (2016) · Gerontology · doi:10.1159/000452972 · Cited by 22
Park, C., Jeoung, Y.-H., Uh, K., Park, K., Bridge, J., Powell, A. M., Li, J., Pence, L., Zhang, L., Liu, T., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.11.011 · Cited by 22
Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9
Kaczmarczyk, L., Mende, Y., Zevnik, B., & Jackson, W. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154604 · Cited by 22
Genetically engineered birds; pre-CRISPR and CRISPR era
Dehdilani, N., Taemeh, S. Y., Goshayeshi, L., & Dehghani, H. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab196 · Cited by 21
Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV Interface
Menchon, G., Bombarde, O., Trivedi, M., Négrel, A., Inard, C., Giudetti, B., Baltas, M., Milon, A., Modesti, M., Czaplicki, G., et al. (2016) · Scientific Reports · doi:10.1038/srep22878 · Cited by 21
CRISPR‐Cas‐Assisted Multiplexing (CAM): Simple Same‐Day Multi‐Locus Engineering in Yeast
Walter, J. M., Chandran, S. S., & Horwitz, A. A. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25375 · Cited by 21
Baillat, D., Russell, W. K., & Wagner, E. J. (2016) · Protein Expression and Purification · doi:10.1016/j.pep.2016.08.011 · Cited by 21
Application of Genome Editing Techniques in Immunology
Zych, A. O., Bajor, M., & Zagożdżon, R. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0504-z · Cited by 22
Plant DNA Repair Pathways and Their Applications in Genome Engineering
Que, Q., Chen, Y., Kelliher, T., Skibbe, D. S., Dong, S., & Chilton, M.-D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8991-1_1 · Cited by 23
Zimmerlin, L., & Zambidis, E. T. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111935 · Cited by 21
Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9
Pinzón-Arteaga, C. A., Snyder, M. D., Lazzarotto, C. R., Moreno, N. F., Juras, R., Raudsepp, T., Golding, M. C., Varner, D. D., & Long, C. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-62723-3 · Cited by 21
Advances and challenges in genetic technologies to produce single-sex litters
Douglas, C., & Turner, J. M. A. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008898 · Cited by 21
Fañanas-Baquero, S., Bustamante, O. Q., Dever, D. P., Alberquilla, O., Sánchez‐Domínguez, R., Camarena, J., Ojeda-Pérez, I., Dessy-Rodríguez, M., Turk, R., Schubert, M. S., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.001 · Cited by 22
CRISPR/Cas gene editing in the human germline
Bekaert, B., Boel, A., Cosemans, G., Witte, L. D., Menten, B., & Heindryckx, B. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.012 · Cited by 21
Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice
Tsuji, S., Stephens, C. J., Bortolussi, G., Zhang, F., Baj, G., Jang, H., de Alencastro, G., Muro, A. F., Pekrun, K., & Kay, M. A. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01240-2 · Cited by 23
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M. B., Ingram, J. R., & Ploegh, H. L. (2016) · Nature Biotechnology · doi:10.1038/nbt0216-210c · Cited by 21
Self-citationBazick, H., Mao, H., Niehaus, J. K., Wolter, J. M., & Zylka, M. J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.032 · Cited by 20
Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations
Abuhamad, A. Y., Zamberi, N. N. M., Ling, S., Naes, S. M., Yusuf, S. N. H. M., Tajudin, A. A., Mohtar, M. A., Syahir, A., & Syafruddin, S. E. (2022) · Cells · doi:10.3390/cells11101612 · Cited by 20
Baculovirus-based genome editing in primary cells
Mansouri, M., Ehsaei, Z., Taylor, V., & Berger, P. (2017) · Plasmid · doi:10.1016/j.plasmid.2017.01.003 · Cited by 20
Use of CRISPR/Cas9 to model brain diseases
Yan, S., Tu, Z., Li, S., & Li, X. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.003 · Cited by 20
AIRE is a critical spindle-associated protein in embryonic stem cells
Gu, B., Lambert, J., Cockburn, K., Gingras, A., & Rossant, J. (2017) · eLife · doi:10.7554/elife.28131 · Cited by 20
Jayavaradhan, R., Pillis, D. M., & Malik, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.005 · Cited by 20
Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
Xia, E., Duan, R. C., Shi, F., Seigel, K. E., Grasemann, H., & Hu, J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.10.015 · Cited by 20
Chen, X., Castro, S. A., Liu, Q., Hu, W., & Zhang, S. (2018) · Methods · doi:10.1016/j.ymeth.2018.12.002 · Cited by 20
Gene Editing in Clinical Practice: Where are We?
Mittal, R. D. (2019) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-018-0804-4 · Cited by 21
Eki, R., She, J., Parlak, M., Benamar, M., Du, K., Kumar, P., & Abbas, T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa897 · Cited by 20
RNA activation of haploinsufficient Foxg1 gene in murine neocortex
Fimiani, C., Goina, E., Su, Q., Gao, G., & Mallamaci, A. (2016) · Scientific Reports · doi:10.1038/srep39311 · Cited by 22
Gene editing and CRISPR-dependent homology-mediated end joining
Ruis, B. L., Bielinsky, A., & Hendrickson, E. A. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01442-z · Cited by 20
Making gene editing a therapeutic reality
Conboy, I. M., Murthy, N., Etienne, J., & Robinson, Z. R. (2018) · F1000Research · doi:10.12688/f1000research.16106.1 · Cited by 19
Deletion of mFICD AMPylase alters cytokine secretion and affects visual short-term learning in vivo
McCaul, N., Porter, C. M., Becker, A. M. D., Tang, C.-H. A., Wijne, C., Chatterjee, B. K., Bousbaine, D., Bilate, A. M. B., Hu, C. A., Ploegh, H. L., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100991 · Cited by 19
Self-citationRai, R., Naseem, A., Vetharoy, W., Steinberg, Z., Thrasher, A. J., Santilli, G., & Cavazza, A. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.02.014 · Cited by 19
Enhanced Biosynthesis Performance of Heterologous Proteins in CHO-K1 Cells Using CRISPR-Cas9
Wang, W., Zheng, W., Hu, F., He, X., Wu, D., Zhang, W., Liu, H., & Ma, X. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00375 · Cited by 19
CRISPR-FRT targets shared sites in a knock-out collection for off-the-shelf genome editing
Swings, T., Marciano, D. C., Atri, B., Bosserman, R. E., Wang, C., Leysen, M., Bonte, C., Schalck, T., Furey, I. M., den Bergh, B. V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04651-5 · Cited by 19
NHEJ inhibitor SCR7 and its different forms: Promising CRISPR tools for genome engineering
Ray, U., Vartak, S. V., & Raghavan, S. C. (2020) · Gene · doi:10.1016/j.gene.2020.144997 · Cited by 19
Rapid genome editing by CRISPR-Cas9-POLD3 fusion
Reint, G., Li, Z., Labun, K., Keskitalo, S., Soppa, I., Mamia, K., Tölö, E., Szymanska, M., Meza-Zepeda, L. A., Lorenz, S., et al. (2021) · eLife · doi:10.7554/elife.75415 · Cited by 19
Next-generation mammalian genetics toward organism-level systems biology
Susaki, E. A., Ukai, H., & Ueda, H. R. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0015-2 · Cited by 21
CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
Rahman, S., Datta, M., Kim, J., & Jan, A. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.014 · Cited by 19
Hazel, K., Singh, D., He, S., Guertin, Z., Husser, M. C., & Helfield, B. L. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.013 · Cited by 18
CRISPR/Cas9 as a Mutagenic Factor
Shumega, A. R., Pavlov, Y. I., Chirinskaite, A. V., Rubel, A. A., Inge-Vechtomov, S. G., & Stepchenkova, E. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020823 · Cited by 18
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
Lau, C., Liang, Q., & Zhu, H. (2024) · Transgenic Research · doi:10.1007/s11248-024-00404-x · Cited by 19
Wu, J., & Belmonte, J. C. I. (2016) · Transgenic Research · doi:10.1007/s11248-016-9930-z · Cited by 18
To Crispr And Beyond: The Evolution Of Genome Editing In Stem Cells
Chen, K.-Y. M., & Knoepfler, P. S. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0107 · Cited by 18
Modeling Cancer in the CRISPR Era
Ventura, A., & Dow, L. E. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050455 · Cited by 18
Millette, K., & Georgia, S. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0947-3 · Cited by 18
Viral Vectors, Engineered Cells and the CRISPR Revolution
DiCarlo, J. E., Deeconda, A., & Tsang, S. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-63904-8_1 · Cited by 19
Antony, J. S., Haque, A. K. M. A., Lamsfus‐Calle, A., Daniel-Moreno, A., Mezger, M., & Kormann, M. (2018) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.10 · Cited by 20
Replacing murine insulin 1 with human insulin protects NOD mice from diabetes
Elso, C. M., Scott, N. A., Mariana, L., Masterman, E. I., Sutherland, A. P. R., Thomas, H. E., & Mannering, S. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225021 · Cited by 18
The internal region of CtIP negatively regulates DNA end resection
Howard, S. M., Ceppi, I., Anand, R., Geiger, R., & Ćejka, P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa273 · Cited by 19
Lee, C.-H., & Grey, F. E. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00280 · Cited by 18
The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs
Bayat, H., Omidi, M., Rajabibazl, M., Sabri, S., & Rahimpour, A. (2017) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1607.07005 · Cited by 18
The pigmented epithelium, a bright partner against photoreceptor degeneration
Letelier, J., Bovolenta, P., & Martínez‐Morales, J. R. (2017) · Journal of Neurogenetics · doi:10.1080/01677063.2017.1395876 · Cited by 20
CRISPR/Cas9 therapeutics for liver diseases
Aravalli, R. N., & Steer, C. J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26627 · Cited by 19
Savić, N., Ringnalda, F. C. A. S., Berk, C., Bargsten, K., Hall, J., Jínek, M., & Schwank, G. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3136 · Cited by 18
Gaj, T., & Schaffer, D. V. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot086868 · Cited by 19
CRISPR/Cas-Based Gene Editing Tools for Large DNA Fragment Integration
Yang, S., Hu, G., Wang, J., & Song, J. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00632 · Cited by 17
Metadata
- Authors
- Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Ploegh, Hidde L
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2015-03-23
- Volume
- 33
- Issue
- 5
- Pages
- 538-542
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4618510
- OpenAlex
- W2008147758
- Cited by
- 1,137
- References
- 32
- Citations by year
- 2026: 39 · 2025: 58 · 2024: 62 · 2023: 67 · 2022: 108 · 2021: 101 · 2020: 117 · 2019: 122 · 2018: 125 · 2017: 139 · 2016: 143 · 2015: 55
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-02-05)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI087879)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, genome editing efficiency, non-homologous end joining, homology-directed repair, DNA ligase IV, DNA double-strand break repair, zinc finger nucleases, TALEN
- MeSH terms
- DNA Ligase ATP, Animals, Cell Line, DNA Repair, Genetic Engineering, DNA Ligases, Pyrimidines, Schiff Bases, Zinc Fingers, Genome, Mice, DNA Breaks, Double-Stranded, Homologous Recombination, DNA End-Joining Repair, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review